Further randomized trials are needed to define optimal dosing, longterm safety, and its role among sleepoptimizing peptides such as CJC1295, Ipamorelin, and Epitalon Key sleepoptimizing peptides highlighted in the article are CJC1295, Ipamorelin, Delta SleepInducing Peptide (DSIP), and Sermorelin
BPC 157 reduces brain damage in multiple sclerosis
Protocol 4: degenerative disc disease and facet arthritis (advanced) Goal: Slow degenerative processes and support tissue quality in chronic spinal degeneration Peptides: BPC-157 : 500mcg twice daily ongoing GHK-Cu : 2mg daily for tissue regeneration KPV : 300mcg daily for anti-inflammatory effects Optional : TB-500 2mg weekly for systemic support Duration: Extended protocols, potentially cycling on and off Why this works: Degenerative conditions require ongoing support rather than acute treatment
What Are Key Recommendations for Supporting MTHFR Mutations
Its potency can begin to decline, and the risk of contamination begins to climb